1. Evaluation of financial conflicts of interest and drug statements in the coronavirus disease 2019 clinical practice guideline in Japan. (March 2022) Authors: Hashimoto, Takanao; Murayama, Anju; Mamada, Hanano; Saito, Hiroaki; Tanimoto, Tetsuya; Ozaki, Akihiko Journal: Clinical microbiology and infection Issue: Volume 28:Number 3(2022) Page Start: 460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Financial Relationships Between Pharmaceutical Companies and Rheumatologists in Japan Between 2016 and 2019. Issue 3 (7th April 2023) Authors: Murayama, Anju; Mamada, Hanano; Shigeta, Haruki; Yoshinaga, Takamichi; Saito, Hiroaki; Yamashita, Erika; Tanimoto, Tetsuya; Ozaki, Akihiko Journal: Journal of clinical rheumatology Issue: Volume 29:Issue 3(2023) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Observational study of financial and non-financial conflicts of interest among the Japanese government advisory board members concerning coronavirus disease 2019. Issue 4 (27th January 2023) Authors: Mamada, Hanano; Murayama, Anju; Ozaki, Akihiko; Hashimoto, Takanao; Saito, Hiroaki; Sawano, Toyoaki; Yamashita, Erika; Bhandari, Divya; Shrestha, Sunil; Tanimoto, Tetsuya Journal: Medicine Issue: Volume 102:Issue 4(2023) Page Start: e32776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗